Biotie Therapies' P2P Acquisition

Biotie Therapies raised a round of funding on January 19, 2016. Investors include Acorda Therapeutics.

Biotie is a specialized drug development company focused on the development of drugs for neurodegenerative and psychiatric disorders (e.g. Parkinson's disease, Alzheimer's disease and other cognitive …

Articles about Biotie Therapies' P2P Acquisition: